Press "Enter" to skip to content

VIDEO: AstraZeneca executive highlights ‘extensive’ development program for acalabrutinib in CLL – Healio

admin 0

VIDEO: AstraZeneca executive highlights ‘extensive’ development program for acalabrutinib in CLL  Healio

CHICAGO — Michelle Dawson, PhD, U.S. medical affairs franchise head for hematology at AstraZeneca, spoke with HemOnc Today at ASCO Annual Meeting …

“lymphoma cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *